<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Polymorphisms in Turkish population</title>
	<atom:link href="http://polymorphisms.info/feed" rel="self" type="application/rss+xml" />
	<link>http://polymorphisms.info</link>
	<description></description>
	<lastBuildDate>Thu, 19 May 2011 20:57:51 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Multifactor dimensionality reduction analysis of MTHFR, PAI-1, ACE, PON1, and eNOS gene polymorphisms in patients with early onset coronary artery disease.</title>
		<link>http://polymorphisms.info/gene-polymorphisms/multifactor-dimensionality-reduction-analysis-of-mthfr-pai-1-ace-pon1-and-enos-gene-polymorphisms-in-patients-with-early-onset-coronary-artery-disease.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/multifactor-dimensionality-reduction-analysis-of-mthfr-pai-1-ace-pon1-and-enos-gene-polymorphisms-in-patients-with-early-onset-coronary-artery-disease.html#comments</comments>
		<pubDate>Thu, 19 May 2011 20:57:50 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene polymorphisms]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=406</guid>
		<description><![CDATA[Eur J Cardiovasc Prev Rehabil. 2011 Feb 22. [Epub ahead of print]
Agirbasli M, Guney A, Ozturhan H, Agirbasli D, Ulucan K, Sevinc D, Kirac D, Ryckman K, Williams S.

Source
Department of Cardiology, Faculty of Medicine, Marmara University, Istanbul, Turkey.


Abstract
Background: Association studies in the Turkish population have investigated the single locus effects of different gene polymorphisms on [...]]]></description>
			<content:encoded><![CDATA[<div>Eur J Cardiovasc Prev Rehabil. 2011 Feb 22. [Epub ahead of print]</div>
<div>Agirbasli M, Guney A, Ozturhan H, Agirbasli D, Ulucan K, Sevinc D, Kirac D, Ryckman K, Williams S.</div>
<div>
<h3>Source</h3>
<p>Department of Cardiology, Faculty of Medicine, Marmara University, Istanbul, Turkey.</p>
</div>
<div>
<h3>Abstract</h3>
<p>Background: Association studies in the Turkish population have investigated the single locus effects of different gene polymorphisms on coronary artery disease (CAD). CAD is a complex polygenic disease that involves complex interactions among multiple genetic and environmental conditions. Design: We evaluated associations of five candidate genetic polymorphisms (methylene tetrahydrofolate reductase C677T, plasminogen activator inhibitor 4G/5G, endothelial nitric oxide synthase (eNOS) 3-27 base pair repeat, insertion, or deletion of a 287 bp Alu repeat sequence polymorhism of angiotensin I converting enzyme, and paraoxonase Gln192Arg PON1 polymorphisms) with the presence and extent of early onset CAD. Methods: DNA was isolated and amplified from 90 consecutive patients with angiographically proven early onset CAD (ages 41 ± 5 for men, 49 ± 7 for women) and also from 90 control subjects with no significant coronary obstruction angiographically (ages 42 ± 5 for men, 48 ± 6 for women). Multifactor dimensionality reduction (MDR) analysis was performed to identify a model of CAD based on both genetic and conventional risk factors. Results: MDR analysis detected a significant model with four genes (prediction success ∼ 61%, p = 0.03). When the total number of the conventional risk factors is analysed with the candidate polymorphisms, a different model is identified that includes three of the four genes from the above model and achieves a similar prediction of CAD as the gene only model. Conclusion: These data indicate that gene-gene and gene-environmental risk interactions form significant models in predicting early onset CAD.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/multifactor-dimensionality-reduction-analysis-of-mthfr-pai-1-ace-pon1-and-enos-gene-polymorphisms-in-patients-with-early-onset-coronary-artery-disease.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>IL-1 cluster gene polymorphisms in Turkish patients with Behçet&#8217;s disease.</title>
		<link>http://polymorphisms.info/behcets-disease/il-1-cluster-gene-polymorphisms-in-turkish-patients-with-behcets-disease.html</link>
		<comments>http://polymorphisms.info/behcets-disease/il-1-cluster-gene-polymorphisms-in-turkish-patients-with-behcets-disease.html#comments</comments>
		<pubDate>Thu, 19 May 2011 20:56:37 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Behçet's disease]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=404</guid>
		<description><![CDATA[Int J Immunogenet. 2011 Mar 22. doi: 10.1111/j.1744-313X.2011.01006.x. [Epub ahead of print]
Ozçimen AA, Dilek K, Bingöl U, Sarıcaoğlu H, Sarandöl A, Taşkapılıoğlu O, Yurtkuran M, Yurtkuran MA, Oral HB.

Source
Department of Biology, Mersin University Faculty of Science and Art, Mersin, Turkiye Department of Nephrology &#38; Rheumatology, Uludag University Faculty of Medicine, Bursa, Turkiye Department of Physical [...]]]></description>
			<content:encoded><![CDATA[<div>Int J Immunogenet. 2011 Mar 22. doi: 10.1111/j.1744-313X.2011.01006.x. [Epub ahead of print]</div>
<div>Ozçimen AA, Dilek K, Bingöl U, Sarıcaoğlu H, Sarandöl A, Taşkapılıoğlu O, Yurtkuran M, Yurtkuran MA, Oral HB.</div>
<div>
<h3>Source</h3>
<p>Department of Biology, Mersin University Faculty of Science and Art, Mersin, Turkiye Department of Nephrology &amp; Rheumatology, Uludag University Faculty of Medicine, Bursa, Turkiye Department of Physical Medicine &amp; Rehabilitation, Uludag University Faculty Of Medicine, Bursa, Turkiye Department of Dermatology, Uludag University Faculty Of Medicine, Bursa, Turkiye Department of Psychiatry, Uludag University Faculty of Medicine, Bursa, Turkiye Department of Neurology, Uludag University Faculty Of Medicine, Bursa, Turkiye Immunology Unit, Department of Medical Microbiology, Uludag University Faculty of Medicine, Bursa, Turkiye.</p>
</div>
<div>
<h3>Abstract</h3>
<p>Several cytokine genes may play crucial roles in host susceptibility to Behçet&#8217;s Disease (BD), since the cytokine production capacity varies among individuals and depends on the cytokine gene polymorphisms. The association of the IL-1 cluster gene polymorphisms with the development of BD was investigated in this study. DNA samples were obtained from a Turkish population of 97 patients with BD, and 77 healthy control subjects. All genotyping (IL-1α, IL-1β, IL-1R and IL-1Ra) experiments were performed using sequence specific primers PCR (PCR-SSP). When compared to the healthy controls, the frequencies of IL-1Ra IL-1α and IL-1R gene polymorphisms were not significantly different in BD patients. The frequency of IL-1β-511 TT genotype was higher in the BD group in comparison to the control group. Interestingly, we demonstrated that IL-1 β +3962 gene polymorphism seems to be associated with the presence of Erythema nodosum in BD patients. Our data suggest that polymorphisms in IL-1β gene may affect host susceptibility to BD. In order to confirm the biological significance of our results, further studies should be performed in a large-scale study and/or in different ethnic groups.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/behcets-disease/il-1-cluster-gene-polymorphisms-in-turkish-patients-with-behcets-disease.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DNA repair enzyme polymorphisms and oxidative stress in a Turkish population with gastric carcinoma.</title>
		<link>http://polymorphisms.info/cancer-kanser/dna-repair-enzyme-polymorphisms-and-oxidative-stress-in-a-turkish-population-with-gastric-carcinoma.html</link>
		<comments>http://polymorphisms.info/cancer-kanser/dna-repair-enzyme-polymorphisms-and-oxidative-stress-in-a-turkish-population-with-gastric-carcinoma.html#comments</comments>
		<pubDate>Thu, 19 May 2011 20:54:57 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer (Kanser)]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=402</guid>
		<description><![CDATA[Mol Biol Rep. 2011 Mar 9. [Epub ahead of print]
Engin AB, Karahalil B, Engin A, Karakaya AE.

Source
Department of Toxicology, Faculty of Pharmacy, Gazi University, 06330, Hipodrom, Ankara, Turkey, abengin@gmail.com.


Abstract
Although the developmental stages of gastric carcinoma are still not clear, the constantly generated reactive oxygen and nitrogen species (ROS/RNS) may contribute to the process of carcinogenesis [...]]]></description>
			<content:encoded><![CDATA[<div>Mol Biol Rep. 2011 Mar 9. [Epub ahead of print]</div>
<div>Engin AB, Karahalil B, Engin A, Karakaya AE.</div>
<div>
<h3>Source</h3>
<p>Department of Toxicology, Faculty of Pharmacy, Gazi University, 06330, Hipodrom, Ankara, Turkey, abengin@gmail.com.</p>
</div>
<div>
<h3>Abstract</h3>
<p>Although the developmental stages of gastric carcinoma are still not clear, the constantly generated reactive oxygen and nitrogen species (ROS/RNS) may contribute to the process of carcinogenesis by interacting with DNA. 8-oxoguanine DNA glycosylase-1 (OGG1) is an enzyme involved in base excision repair of 8-oxoguanine that is one of the premutagenic lesions generated by ROS in DNA. The bulky adducts, are recognized and repaired by nucleotid excision repair (NER) enzymes, including xeroderma pigmentosum C and D (XPC, XPD). Eligible 106 gastric cancer patients and 116 cancer-free individuals constituted the study and control groups, respectively. Association between OGG1 Ser326Cys, XPC Lys939Gln, XPD Lys751Gln polymorphisms and the susceptibility tho cancer and the oxidative stress status were evaluated. DNA was extracted from peripheral blood cells and genotypes were determined by using PCR-RFLP. Serum nitric oxide, albumin concentrations, total antioxidant status and Helicobacter pylori IgG were determined. Serum albumin and nitric oxide of cancer patients were lower than that of the controls (P &lt; 0.05). None of the evaluated polymorphisms or Helicobacter pylori IgG seropositivity associated with increased risk of gastric cancer, despite of the increased oxidative stress in cancer patients.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/cancer-kanser/dna-repair-enzyme-polymorphisms-and-oxidative-stress-in-a-turkish-population-with-gastric-carcinoma.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Investigation of CTLA-4 and CD28 gene polymorphisms in patients with diabetes mellitus type 2 using PCR-RFLP in a Turkish population.</title>
		<link>http://polymorphisms.info/gene-polymorphisms/diabetes-mellitus/investigation-of-ctla-4-and-cd28-gene-polymorphisms-in-patients-with-diabetes-mellitus-type-2-using-pcr-rflp-in-a-turkish-population.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/diabetes-mellitus/investigation-of-ctla-4-and-cd28-gene-polymorphisms-in-patients-with-diabetes-mellitus-type-2-using-pcr-rflp-in-a-turkish-population.html#comments</comments>
		<pubDate>Thu, 19 May 2011 20:53:32 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Diabetes Mellitus]]></category>
		<category><![CDATA[Diabetic Retinopathy]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=398</guid>
		<description><![CDATA[West Indian Med J. 2010 Jun;59(3):235-40.
Uzer E, Dilmec F, Akkafa F, Boduroglu O, van Kuilenburg AB.

Source
Department of Internal Medicine, Faculty of Medicine, Harran University, Sanliurfa, Turkey.


Abstract
OBJECTIVE:
The aim of this study is to investigate whether specific polymorphisms in the CTLA-4 and CD28 gene are associated with Type 2 diabetes mellitus (T2DM).
METHODS:
Blood samples were collected from 241 [...]]]></description>
			<content:encoded><![CDATA[<div>West Indian Med J. 2010 Jun;59(3):235-40.</div>
<div>Uzer E, Dilmec F, Akkafa F, Boduroglu O, van Kuilenburg AB.</div>
<div>
<h3>Source</h3>
<p>Department of Internal Medicine, Faculty of Medicine, Harran University, Sanliurfa, Turkey.</p>
</div>
<div>
<h3>Abstract</h3>
<h4>OBJECTIVE:</h4>
<p>The aim of this study is to investigate whether specific polymorphisms in the CTLA-4 and CD28 gene are associated with Type 2 diabetes mellitus (T2DM).</p>
<h4>METHODS:</h4>
<p>Blood samples were collected from 241 individuals (72 patients with T2DM and 169 healthy individuals) and DNA was isolated. A polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was used to detect the frequencies of CTLA-4 NM_005214.3:c.49A &gt; G and c.-319C &gt; T, and CD28 NM_006139.1:c.534+17T &gt; C polymorphisms in T2DM patients in the Sanliurfa Population.</p>
<h4>RESULTS:</h4>
<p>The data suggested that body mass index (BMI), total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-c) and haemoglobin A1c (HbA1c) were significantly higher in T2DM patients than in the control individuals (p &lt; 0.05). No significant differences were observed for the frequencies of c.49A &gt; G, c.-319C &gt; T genotype and allele of CTLA-4 gene and c.534+17T &gt; C of the CD28 gene in T2DM patients compared to healthy individuals (p &gt; 0.05).</p>
<h4>CONCLUSION:</h4>
<p>The CTLA-4 gene c.49A &gt; G and c.-319C &gt; T and CD28 gene c.534+ 17T &gt; C polymorphisms did not represent an important risk factor for this disease in a group of the Turkish population.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/diabetes-mellitus/investigation-of-ctla-4-and-cd28-gene-polymorphisms-in-patients-with-diabetes-mellitus-type-2-using-pcr-rflp-in-a-turkish-population.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Are PON1 Q/R 192 and M/L 55 polymorphisms risk factors for diabetes complications in Turkish population?</title>
		<link>http://polymorphisms.info/gene-polymorphisms/diabetes-mellitus/are-pon1-qr-192-and-ml-55-polymorphisms-risk-factors-for-diabetes-complications-in-turkish-population-2.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/diabetes-mellitus/are-pon1-qr-192-and-ml-55-polymorphisms-risk-factors-for-diabetes-complications-in-turkish-population-2.html#comments</comments>
		<pubDate>Thu, 19 May 2011 20:51:52 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Diabetes Mellitus]]></category>
		<category><![CDATA[Diabetic Retinopathy]]></category>
		<category><![CDATA[ankara turkey]]></category>
		<category><![CDATA[ankara university]]></category>
		<category><![CDATA[diabetic complications]]></category>
		<category><![CDATA[diabetic patients]]></category>
		<category><![CDATA[faculty of pharmacy]]></category>
		<category><![CDATA[Genotyping]]></category>
		<category><![CDATA[human serum]]></category>
		<category><![CDATA[ldl particles]]></category>
		<category><![CDATA[pharmacy department]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[polymorphisms]]></category>
		<category><![CDATA[risk factors for diabetes]]></category>
		<category><![CDATA[turkish population]]></category>
		<category><![CDATA[type 2 diabetes]]></category>
		<category><![CDATA[type 2 diabetes mellitus]]></category>
		<category><![CDATA[university faculty]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=396</guid>
		<description><![CDATA[Clin Biochem. 2011 Apr;44(5-6):372-6. Epub 2011 Jan 9.
Altuner D, Suzen SH, Ates I, Koc GV, Aral Y, Karakaya A.

Source
Ankara University, Faculty of Pharmacy, Department of Toxicology, 06100, Tandogan, Ankara, Turkey.


Abstract
OBJECTIVES:
We investigated whether the human serum paraoxonase (PON1) Q/R 192 and M/L 55 polymorphisms are associated with the complications of the type 2 diabetes (T2D).
DESIGN AND [...]]]></description>
			<content:encoded><![CDATA[<div>Clin Biochem. 2011 Apr;44(5-6):372-6. Epub 2011 Jan 9.</div>
<div>Altuner D, Suzen SH, Ates I, Koc GV, Aral Y, Karakaya A.</div>
<div>
<h3>Source</h3>
<p>Ankara University, Faculty of Pharmacy, Department of Toxicology, 06100, Tandogan, Ankara, Turkey.</p>
</div>
<div>
<h3>Abstract</h3>
<h4>OBJECTIVES:</h4>
<p>We investigated whether the human serum paraoxonase (PON1) Q/R 192 and M/L 55 polymorphisms are associated with the complications of the type 2 diabetes (T2D).</p>
<h4>DESIGN AND METHODS:</h4>
<p>Study group was consisted of 50 healthy subjects and 100 type 2 diabetes mellitus (DM) patients. Following measuring of serum PON1 activity, isolation of DNA and genotyping analyses were performed.</p>
<h4>RESULTS:</h4>
<p>PON1 activity of the patients with complications was significantly reduced by 23.5% compared to the group of diabetic patients and by 26.3% than the controls. According to multivariate analysis, we observed a three times significant effect of Q/R 192 polymorphism on the susceptibility to the occurrence of complications.</p>
<h4>CONCLUSIONS:</h4>
<p>Protective effects of paraoxonase against peroxidation of LDL particles are important in T2D complications. Although both of the two polymorphisms are associated, 192 polymorphism seems to be stronger predictor of the risk of diabetic complications.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/diabetes-mellitus/are-pon1-qr-192-and-ml-55-polymorphisms-risk-factors-for-diabetes-complications-in-turkish-population-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Lack of association between IL-1 and IL-6 gene polymorphisms and myocardial infarction in Turkish population.</title>
		<link>http://polymorphisms.info/cancer-kanser/lack-of-association-between-il-1-and-il-6-gene-polymorphisms-and-myocardial-infarction-in-turkish-population-2.html</link>
		<comments>http://polymorphisms.info/cancer-kanser/lack-of-association-between-il-1-and-il-6-gene-polymorphisms-and-myocardial-infarction-in-turkish-population-2.html#comments</comments>
		<pubDate>Thu, 19 May 2011 20:48:37 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer (Kanser)]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=394</guid>
		<description><![CDATA[Int J Immunogenet. 2011 Jan 4. doi: 10.1111/j.1744-313X.2010.00988.x. [Epub ahead of print]
Coker A, Arman A, Soylu O, Tezel T, Yildirim A.

Source
The Faculty of Science and Letters, Istanbul Kultur University, Istanbul, Turkey The Faculty of Engineering, Marmara University, Istanbul, Turkey The Department of Cardiology, Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey.


Abstract
Inflammation [...]]]></description>
			<content:encoded><![CDATA[<div>Int J Immunogenet. 2011 Jan 4. doi: 10.1111/j.1744-313X.2010.00988.x. [Epub ahead of print]</div>
<div>Coker A, Arman A, Soylu O, Tezel T, Yildirim A.</div>
<div>
<h3>Source</h3>
<p>The Faculty of Science and Letters, Istanbul Kultur University, Istanbul, Turkey The Faculty of Engineering, Marmara University, Istanbul, Turkey The Department of Cardiology, Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey.</p>
</div>
<div>
<h3>Abstract</h3>
<p>Inflammation and genetics play a key role in the pathogenesis of atherosclerosis and its clinical result myocardial infarction (MI). Proinflammatory cytokines, IL-1 and IL-6, have been shown to play essential roles in developmental stages of coronary artery plaque formation. The aim of this study was to determine the association between IL-1 [IL-1RN, IL-1β (-511, +3953)], IL-6 [-174, -572, -597] gene polymorphisms and MI in Turkish population. A total of 402 people were participated; 235 healthy control subjects and 167 MI patients (MI &lt; 40, n: 72; MI &gt; 40, n: 95). Polymerase chain reaction (PCR) was used to determine the genotype of IL-1RN, whereas the genotypes of IL-1β (-511, +3953) and IL-6 (-174, -572, -597) were determined using PCR followed with restriction digestion analysis. There was no significant difference between MI and controls for IL-1RN, IL-1β-511, +3953 (P: 0.875, 0.608, 0.442) and IL-6 -174, -572, -597 (P: 0.977, 0.632, 0.584) gene polymorphisms. Lack of association was observed between MI at younger age (MI &lt; 40) and either IL-1RN VNTR, IL-1β-511, +3953 (P: 0.878, 0.732, 0.978) or IL-6 -174, -572, -597 (P: 0.313, 0.654, 0.552) gene polymorphisms. This study demonstrated that there was not any association between IL-1, IL-6 gene variants and MI in Turkish population. In addition, IL-1 and IL-6 gene polymorphisms did not affect MI at younger age (MI &lt; 40) or older age (MI &gt; 40). Thus, IL-1 and IL-6 single nucleotide polymorphisms may not be a risk factor for susceptibility to MI in Turkish population.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/cancer-kanser/lack-of-association-between-il-1-and-il-6-gene-polymorphisms-and-myocardial-infarction-in-turkish-population-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population.</title>
		<link>http://polymorphisms.info/gene-polymorphisms/association-of-ape1-and-hogg1-polymorphisms-with-colorectal-cancer-risk-in-a-turkish-population.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/association-of-ape1-and-hogg1-polymorphisms-with-colorectal-cancer-risk-in-a-turkish-population.html#comments</comments>
		<pubDate>Thu, 19 May 2011 20:43:14 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene polymorphisms]]></category>
		<category><![CDATA[abstract background]]></category>
		<category><![CDATA[bugra]]></category>
		<category><![CDATA[cacina]]></category>
		<category><![CDATA[cancer results]]></category>
		<category><![CDATA[cancer risk]]></category>
		<category><![CDATA[colon cancer]]></category>
		<category><![CDATA[dna repair genes]]></category>
		<category><![CDATA[liver metastasis]]></category>
		<category><![CDATA[med res]]></category>
		<category><![CDATA[polymerase chain reaction]]></category>
		<category><![CDATA[polymerase chain reaction pcr]]></category>
		<category><![CDATA[proximal colon]]></category>
		<category><![CDATA[restriction fragment length]]></category>
		<category><![CDATA[restriction fragment length polymorphism]]></category>
		<category><![CDATA[turkish population]]></category>
		<category><![CDATA[zeybek]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=390</guid>
		<description><![CDATA[Curr Med Res Opin. 2011 May 12. [Epub ahead of print]
Canbay E, Cakmakoglu B, Zeybek U, Sozen S, Cacina C, Gulluoglu M, Balik E, Bulut T, Yamaner S, Bugra D.

Source
Basaksehir State Hospital, Department of General Surgery , Basaksehir, Istanbul , Turkey.


Abstract
Abstract Background: There is growing evidence describing DNA repair genes polymorphisms are related to increased [...]]]></description>
			<content:encoded><![CDATA[<div>Curr Med Res Opin. 2011 May 12. [Epub ahead of print]</div>
<div>Canbay E, Cakmakoglu B, Zeybek U, Sozen S, Cacina C, Gulluoglu M, Balik E, Bulut T, Yamaner S, Bugra D.</div>
<div>
<h3>Source</h3>
<p>Basaksehir State Hospital, Department of General Surgery , Basaksehir, Istanbul , Turkey.</p>
</div>
<div>
<h3>Abstract</h3>
<p>Abstract Background: There is growing evidence describing DNA repair genes polymorphisms are related to increased cancer risk including colorectal cancer (CRC). The aim of this study was to investigate the associations between the APE1 Asp148Glu, hOGG1 Ser326Cys, XRCC1 Arg399Gln, XRCC3 Thr241Met, XPD Lys751Gln, XPG Asp1104His polymorphisms and CRC risk in Turkish population. Patients and methods: Polymorphisms of APE1 Asp148Glu (rs3136820), hOGG1 Ser326Cys (rs1052133), XRCC1 Arg399Gln(rs25487), XRCC3 Thr241Met (rs861539), XPD Lys751Gln (rs13181), and XPG Asp1104His (rs17655) were determined by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) methods in blood samples of 79 CRC patients at their initial staging and 247 healthy controls. Of the CRC patients, 26 out of 40 were diagnosed with rectal cancer and received neoadjuvant chemoradiotherapy following diagnosis; 39 others were diagnosed as colon cancer. Results: Our preliminary results showed that frequencies of Glu allele of APE1 Asp148Glu and Cys allele of hOGG1 Ser326Cys were higher in CRC patients than in controls (p = 0.006, OR: 3.43; 95% CI: 1.76-6.70; p = 0.000, OR: 2.77; 95% CI: 1.40-5.48, respectively). Higher frequency of Met allele of XRCC3 Thr241Met was detected in patients treated with neoadjuvant chemoradiotherapy (p = 0.024, OR: 5.25; 95% CI: 1.23-23.39) and with proximal colon tumors (p = 0.04, OR: 2; 95% CI: 1.18-3.34). Increased frequency of Ser/Ser genotype of hOGG1 Ser326Cys was found to be associated both with higher grade (p = 0.001, OR: 6.4; 95% CI: 2.69-62.69) and liver metastasis (p = 0.005, OR: 7.5; 95% CI: 0.7-68.36). Conclusion: APE1 Asp148Glu and hOGG1 Ser326Cys polymorphisms might be associated with increasing risk of CRC in a Turkish population. Future studies with larger-sized samples, as well as detecting the association of DNA repair genes with other confounding factors will help elucidate the exact roles of DNA repair genes polymorphisms in development and progression of CRC.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/association-of-ape1-and-hogg1-polymorphisms-with-colorectal-cancer-risk-in-a-turkish-population.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Association of the Angiotensinogen M235T and APO E Gene Polymorphisms in Turkish Type 2 Diabetic Patients with and without Nephropathy.</title>
		<link>http://polymorphisms.info/gene-polymorphisms/association-of-the-angiotensinogen-m235t-and-apo-e-gene-polymorphisms-in-turkish-type-2-diabetic-patients-with-and-without-nephropathy.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/association-of-the-angiotensinogen-m235t-and-apo-e-gene-polymorphisms-in-turkish-type-2-diabetic-patients-with-and-without-nephropathy.html#comments</comments>
		<pubDate>Thu, 19 May 2011 20:41:37 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene polymorphisms]]></category>
		<category><![CDATA[abstract background]]></category>
		<category><![CDATA[angiotensinogen]]></category>
		<category><![CDATA[ankara turkey]]></category>
		<category><![CDATA[apo e gene]]></category>
		<category><![CDATA[diabetic nephropathy]]></category>
		<category><![CDATA[faculty of medicine]]></category>
		<category><![CDATA[gazi university]]></category>
		<category><![CDATA[morbidity and mortality]]></category>
		<category><![CDATA[pcr results]]></category>
		<category><![CDATA[population association]]></category>
		<category><![CDATA[turkish population]]></category>
		<category><![CDATA[type 2 diabetes]]></category>
		<category><![CDATA[university ankara]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=388</guid>
		<description><![CDATA[Ren Fail. 2011;33(5):469-74. Epub 2011 Apr 18.
Reis KA, Ebinç FA, Koç E, Demirci H, Erten Y, Güz G, Derici UB, Bali M, Söylemezoğlu O, Arınsoy T, Sindel S.

Source
Department of Nephrology, Faculty of Medicine, Gazi University , Ankara , Turkey.


Abstract
Background: Diabetic nephropathy (DN) is a leading cause of diabetes-related morbidity and mortality. The aim of this [...]]]></description>
			<content:encoded><![CDATA[<div>Ren Fail. 2011;33(5):469-74. Epub 2011 Apr 18.</div>
<div>Reis KA, Ebinç FA, Koç E, Demirci H, Erten Y, Güz G, Derici UB, Bali M, Söylemezoğlu O, Arınsoy T, Sindel S.</div>
<div>
<h3>Source</h3>
<p>Department of Nephrology, Faculty of Medicine, Gazi University , Ankara , Turkey.</p>
</div>
<div>
<h3>Abstract</h3>
<p>Background: Diabetic nephropathy (DN) is a leading cause of diabetes-related morbidity and mortality. The aim of this study was to evaluate the relationship of AGT M235T and apoprotein E (APO E) gene polymorphism with DN in Turkish patients of Type 2 diabetes, and to compare genotype and allele distributions among DN patients, non-DN patients, and healthy controls. Methods: AGT M235T and APO E genotype and allele analysis were performed in 111 DN patients, 108 non-DN patients, 106 healthy control subjects for APO E genotype, and 100 for AGT M235T genotype polymorphism. APO E and AGT M235T genotype were determined by RFLP-PCR. Results: The frequencies of APO E ε2/3, ε 3/3, ε 3/4 genotypes were 22.7%, 60%, 60%, respectively, among DN patients and 6.6%, 80%, 10.4%, respectively (p &lt; 0.001), in the non-DN patients. The frequencies of AGT M235T MM, MT, TT genotypes among the same groups were 17%, 46%, 37% and 21%, 63%, 16%, respectively (p &lt; 0.02). Having the ε2/3 genotype and TT genotype increased the risk for DN nephropathy [4.8-fold (95% CI: 1.94-11.67), 2.9-fold (95% CI: 1.27-6.69), respectively]. Conclusion: Our study has shown that AGT M235T TT genotype and APO E ε 2/3 genotype may be linked to a risk for DN among Turkish population.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/association-of-the-angiotensinogen-m235t-and-apo-e-gene-polymorphisms-in-turkish-type-2-diabetic-patients-with-and-without-nephropathy.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Role of G Protein β3 Subunit Polymorphisms C825T, C1429T, and G5177A in Turkish Subjects with Essential Hypertension.</title>
		<link>http://polymorphisms.info/gene-polymorphisms/the-role-of-g-protein-%ce%b23-subunit-polymorphisms-c825t-c1429t-and-g5177a-in-turkish-subjects-with-essential-hypertension.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/the-role-of-g-protein-%ce%b23-subunit-polymorphisms-c825t-c1429t-and-g5177a-in-turkish-subjects-with-essential-hypertension.html#comments</comments>
		<pubDate>Thu, 19 May 2011 20:40:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene polymorphisms]]></category>
		<category><![CDATA[allele frequencies]]></category>
		<category><![CDATA[disease mechanisms]]></category>
		<category><![CDATA[essential hypertension]]></category>
		<category><![CDATA[extracellular enzymes]]></category>
		<category><![CDATA[g protein]]></category>
		<category><![CDATA[g proteins]]></category>
		<category><![CDATA[hardy weinberg equilibrium]]></category>
		<category><![CDATA[istanbul turkey]]></category>
		<category><![CDATA[marmara university]]></category>
		<category><![CDATA[multifactorial disorder]]></category>
		<category><![CDATA[nacar]]></category>
		<category><![CDATA[normotensive]]></category>
		<category><![CDATA[orun]]></category>
		<category><![CDATA[polymerase chain reaction]]></category>
		<category><![CDATA[restriction fragment length]]></category>
		<category><![CDATA[restriction fragment length polymorphism]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=386</guid>
		<description><![CDATA[Clin Exp Hypertens. 2011;33(3):202-8. Epub 2011 Apr 8.
Cabadak H, Orun O, Nacar C, Dogan Y, Guneysel O, Fak AS, Kan B.

Source
Department of Biophysics, Marmara University School of Medicine, Istanbul, Turkey.


Abstract
Hypertension is a multifactorial disorder that constitutes a major risk factor for the cardiovascular system. Heterotrimeric G-proteins, which couple receptors for diverse extracellular enzymes or ion [...]]]></description>
			<content:encoded><![CDATA[<div>Clin Exp Hypertens. 2011;33(3):202-8. Epub 2011 Apr 8.</div>
<div>Cabadak H, Orun O, Nacar C, Dogan Y, Guneysel O, Fak AS, Kan B.</div>
<div>
<h3>Source</h3>
<p>Department of Biophysics, Marmara University School of Medicine, Istanbul, Turkey.</p>
</div>
<div>
<h3>Abstract</h3>
<p>Hypertension is a multifactorial disorder that constitutes a major risk factor for the cardiovascular system. Heterotrimeric G-proteins, which couple receptors for diverse extracellular enzymes or ion channels, are correlated with disease mechanisms. Several studies have demonstrated an association between G protein polymorphisms and essential hypertension in some populations, although contradictive results also exist. In this study, we have investigated the potential role of the C825T, C1429T, and G5177A polymorphisms of the β3 subunit of G-proteins in essential hypertension in a group of Turkish subjects. Genomic DNA from 106 normotensive individuals (117.4 ± 13.1, 75.2 ± 10.5; systolic blood pressure (SBP) and diastolic blood pressure (DBP) levels, respectively) and 101 hypertensive subjects (152.3 ± 18.0, 92.5 ± 11.6; SBP and DBP levels, respectively) were studied by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and direct sequencing methods for these polymorphisms. Allele frequencies of the polymorphisms were consistent with Hardy Weinberg equilibrium, except for the C825T polymorphism (χ(2) = 7.8). The frequencies of the 825T and 1429T variants were higher in hypertensive subjects compared to those of controls. Differences between hypertensives and controls were not statistically significant, though difference was very close to significance for C825T (p = 0.056 and 0.099 for 825T and 1429T, respectively). T allele frequency in overall population showed significant association with hypertension for C825T (0.0134). The prevalence of the 5177A-variant was very low and all subjects carrying it were heterozygotes in both groups.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/the-role-of-g-protein-%ce%b23-subunit-polymorphisms-c825t-c1429t-and-g5177a-in-turkish-subjects-with-essential-hypertension.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Microsomal epoxide hydrolase polymorphisms.</title>
		<link>http://polymorphisms.info/gene-polymorphisms/microsomal-epoxide-hydrolase-polymorphisms-2.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/microsomal-epoxide-hydrolase-polymorphisms-2.html#comments</comments>
		<pubDate>Thu, 19 May 2011 20:38:49 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene polymorphisms]]></category>
		<category><![CDATA[arginine]]></category>
		<category><![CDATA[cumhuriyet]]></category>
		<category><![CDATA[detoxification]]></category>
		<category><![CDATA[enzyme activity]]></category>
		<category><![CDATA[exons]]></category>
		<category><![CDATA[genotype frequencies]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[polymorphic]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[polymorphisms]]></category>
		<category><![CDATA[turkish population]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=384</guid>
		<description><![CDATA[Mol Med Report. 2010 Jul-Aug;3(4):723-7. doi: 10.3892/mmr_00000324.
Microsomal epoxide hydrolase polymorphisms.
Pinarbasi H, Silig Y, Pinarbasi E.

Source
Department of Biochemistry, Faculty of Medicine, Cumhuriyet University, 58140 Sivas, Turkey. hpinar2658@gmail.com.


Abstract
Microsomal epoxide hydrolase plays a dual role in the activation and detoxification of carcinogenic compounds. Two polymorphic sites have been described in exons 3 and 4 of the microsomal epoxide [...]]]></description>
			<content:encoded><![CDATA[<div>Mol Med Report. 2010 Jul-Aug;3(4):723-7. doi: 10.3892/mmr_00000324.</div>
<h1>Microsomal epoxide hydrolase polymorphisms.</h1>
<div>Pinarbasi H, Silig Y, Pinarbasi E.</div>
<div>
<h3>Source</h3>
<p>Department of Biochemistry, Faculty of Medicine, Cumhuriyet University, 58140 Sivas, Turkey. hpinar2658@gmail.com.</p>
</div>
<div>
<h3>Abstract</h3>
<p>Microsomal epoxide hydrolase plays a dual role in the activation and detoxification of carcinogenic compounds. Two polymorphic sites have been described in exons 3 and 4 of the microsomal epoxide hydrolase gene that change tyrosine residue 113 to histidine (Tyr113His) and histidine 139 to arginine (His139Arg), respectively. The exon 3 polymorphism reduces enzyme activity by approximately 50%, whereas the exon 4 polymorphism causes a 25% increase in activity. In the present study, the distribution of these polymorphisms in a Turkish population including 625 unrelated healthy individuals was examined using a PCR-RFLP method. The observed genotype frequencies of microsomal epoxide hydrolase exon 3 were 54, 38 and 8% for Tyr113Tyr, Tyr113His and His113His, respectively. Exon 4 genotype frequencies were found to be 69, 29 and 2% for His139His, His139Arg and Arg139Arg, respectively.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/microsomal-epoxide-hydrolase-polymorphisms-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

